Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for acute vaso-occlusive crisis in pediatric sickle cell disease
NCT02801292Phase 3Unknown
- Sponsor
- Augusta University
- Start
- Jul 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ketamine in sickle cell disease (SCD), sponsored by Augusta University. Status: unknown.
02
Drugs
ketamine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02801292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801292.